New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma.

Cells · 2020 · PMC7140695 · PMID 32168869

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not yet significantno p-value reported

In the intention to treat population, there was a trend in favor of Ivosidenib, but it was not yet significant [ 38 , 39 ].

also in 316 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.